Pectolinarigenin suppresses colorectal cancer progression through metabolism-associated signaling
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-12972-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 03.11.2026. Verfasst von Liang Tan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anorectal Surgery, Xinhua Hospital Affiliated to Dalian University, No. 156 Wansui Street, Shahekou District, Dalian, 116000, Liaoning,…. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit nennt 44 Literaturangaben. Gefördert von: The Liaoning Provincial Science and Technology Plan Project, Joint plan of Liaoning Provincial Science and technology program, The Basic Scientific Research Project of Colleges and Universities of Liaoning Provincial Department of Education.
Abstract (Originalsprache)
BACKGROUND: Colorectal cancer (CRC) remains a major global health burden, with metabolic alterations contributing to its malignant behavior. Pectolinarigenin (PEC), a naturally occurring flavonoid, exhibits antitumor activity in several cancers, but its metabolism-associated effects in CRC remain poorly characterized. This study aimed to investigate the anticancer activity of PEC and its effects on glycolysis-associated metabolism and AMPK/FOXO3a-related signaling in CRC. METHODS: PEC targets were predicted using PharmMapper and SwissTargetPrediction and intersected with CRC-related differentially expressed genes. Functional enrichment analysis, protein-protein interaction analysis, LASSO regression, and single-cell RNA sequencing were integrated to identify candidate genes associated with PEC activity. The effects of PEC were evaluated in HT29 and MC38 cells using proliferation, colony formation, invasion, apoptosis, qRT-PCR, and western blotting assays. AMPK/FOXO3a-related signaling changes were examined in both CRC cell models and MC38 tumor tissues, with selected molecular alterations further assessed by immunohistochemistry in MC38 syngeneic tumors. RESULT: PEC suppressed CRC cell proliferation, colony formation, and invasion and promoted apoptosis. PEC treatment reduced the expression of the glycolysis-associated molecules GLUT1, HK2, and LDHA, accompanied by increased AMPK phosphorylation and reduced inhibitory FOXO3a phosphorylation in CRC cells. Integrated bioinformatic analyses identified CA1 and CA7 as candidate genes associated with PEC activity, with both genes predominantly localized to epithelial cell populations in single-cell datasets. PEC increased CA1 and CA7 expression in CRC cells and MC38 tumor tissues. Western blotting of tumor tissues further showed increased p-AMPK and reduced p-FOXO3a levels following PEC treatment, consistent with the corresponding changes observed in CRC cells. Immunohistochemical analysis further confirmed increased p-AMPK, CA1, and CA7 staining and reduced p-FOXO3a staining in PEC-treated tumor tissues. CONCLUSION: PEC exhibits antitumor activity against CRC and is associated with coordinated changes in glycolysis-associated molecules and AMPK/FOXO3a-related signaling. CA1 and CA7 emerged from integrated bioinformatic analyses as metabolism-associated candidate genes and showed consistent expression changes following PEC treatment in CRC cells and tumor tissues. These findings provide a basis for further investigation of the molecular and metabolic responses associated with PEC in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anorectal Surgery, Xinhua Hospital Affiliated to Dalian University, No. 156 Wansui Street, Shahekou District, Dalian, 116000, Liaoning, China.
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Bengbu Medical University, Bengbu, 233000, Anhui, China.
- Department of Anorectal Surgery, Xinhua Hospital Affiliated to Dalian University, No. 156 Wansui Street, Shahekou District, Dalian, 116000, Liaoning, China. 15942813374@163.com.
Förderung
- The Liaoning Provincial Science and Technology Plan Project
- Joint plan of Liaoning Provincial Science and technology program
- The Basic Scientific Research Project of Colleges and Universities of Liaoning Provincial Department of Education
Zitieren
APA
Tan, L., Gao, D., & Zhao, X. F. (2026). Pectolinarigenin suppresses colorectal cancer progression through metabolism-associated signaling. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12972-8
Vancouver
Tan L, Gao D, Zhao XF. Pectolinarigenin suppresses colorectal cancer progression through metabolism-associated signaling. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12972-8
BibTeX
@article{Tan2026,
author = {Tan, Liang and Gao, Dazhi and Zhao, Xue-Feng},
title = {Pectolinarigenin suppresses colorectal cancer progression through metabolism-associated signaling},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-12972-8}
}
EUVIMED